Much digital ink has been spilled about the Yankees’ 2014 payroll, and their possible goal of getting below the $189 million luxury tax threshold to greatly reduce their luxury tax and revenue sharing obligations. In order to get their payroll below that threshold for 2011, the Yankees would likely have to employ some measure of austerity (for the Yankees, at least). This may explain why we have not seen them be very active on the market this offseason, and may lead them to curtail future expenditures. Because we know that the Yankees are perpetually in “win-now” mode, austerity and rebuilding Continue reading A creative way of handling the Yankees’ payroll problem
Jon Heyman reports that the Yankees have come to terms with Andruw Jones on an agreement to bring him back for another campaign in pinstripes, which would seem to settle the fourth outfielder question before it was even asked. The deal will pay Jones a salary of $2 million, with the chance to earn another $1.4 million in incentives. Factoring in the all important luxury tax bill and Jones stands to potentially cost the Yankees about $4.76 million next year.
I’m going to be in the minority on this, but I’m not really a fan of bringing Jones back. Jones is a platoon hitter at this stage of his career who’s good against left-handed pitching, but the Yankees as a team are stronger against southpaws, and while Jones was able to provide good value last year thanks to Jorge Posada‘s struggles against lefties, Jesus Montero figures to slot in as the primary DH this year, which should mean less of a chance for Jones to get in the lineup outside of platooning with Brett Gardner in left. I think there are probably better uses for this money than bringing back Jones, especially if the Yankees are on such a tight budget this winter. Continue reading Yankees re-sign Andruw Jones
As expected, the Yankees have reached an agreement with Andruw Jones to come back for another ride in the Bronx. Jon Heyman has the details: Andruw jones, yankees in agreement. $2M base plus incentives and Jones’ incentives are about $1.4M. Deal is pending physical Awesome. Welcome back, Andruw. Here’s to mashing more lefties!
It’s Hall of Fame season, and though I’ve mostly tried to avoid the largely pointless arguments over every dumb ballot that comes out (I’m not sure, but I suspect some people recycled the same columns they used last year), I do feel it’s incumbent upon me to do my bloggerly duty and pretend that my opinion on this matters somewhat, so after the jump is the ballot I would cast if I was as privileged as this guy to be trusted with such an important duty.
(click “view full post” to continue reading) Continue reading My (hypothetical) Hall of Fame ballot
I’ve said it a lot that I’m not a big fan of Matt Garza. I don’t think he’s a bad pitcher or anything, but I don’t necessarily think he’s as good as made out to be right now, especially after a stellar 2011 that saw him put up 5.0 fWAR for the Cubbies. People point to his stuff and his AL East success (6.0 fWAR in two seasons with the Rays) and say he’d be a perfect #2 starter for the Yankees. I’ve disagreed, citing low ground ball numbers which could hurt him in Yankee Stadium, as well as up-and-down Continue reading A More Comprehensive Matt Garza Post
For over fifty years sports medicine experts have been in a continual state of trying to find a way to expedite the healing process of an injured athlete, attain better healing, and reduce the chance for re-injury. The New York Post reported within the last month Alex Rodriguez received a treatment in Germany called Orthokine for the injured knee that caused him to miss significant playing time this past summer. This treatment is similar to a one performed in the United States called Platelet-rich plasma therapy or PRP.
A brief history of Platelet-rich plasma therapy or PRP
Platelet-rich Plasma therapy, or PRP, is becoming increasingly popular among professional and amateur athletes.
“The thought with PRP is that by concentrating the patients’ platelets we can get a concentration of their growth factors and really enhance the body’s own healing response,” said Dr. Dennis A. Cardone, Associate Professor of the Department of Orthopedics at New York University’s School of Medicine. “The theory is that by injecting this platelet rich plasma we would be able to enhance the body’s healing response. Certainly in theory and on paper it makes sense.”
(click “view full post” to continue reading) Continue reading Doctors and MLB talk PRP and the treatments Alex Rodriguez received
ESPN’s Buster Olney recently had an interesting chart up where he looked at the value that clubs received on the largest contracts that have even been issued. Here’s the list: Dollars spent per win above replacement in completed $100 million contracts, through 2011: Player Contract WAR $/WAR Albert Pujols 7-year/$100M 59.0 $1.70M Alex Rodriguez 10-year/$252M 71.6 $3.52M Carlos Beltran 7-year/$119M 32.2 $3.70M Derek Jeter 10-year/$189M 48.0 $3.94M Kevin Brown 7-year/$105M 26.2 $4.01M Todd Helton 9-year/$141.5M 32.9 $4.30M Manny Ramirez 8-year/$160M 34.2 $4.68M Jason Giambi 7-year/$120M 21.9 $5.48M Ken Griffey, Jr 9-year/$116.5M 11.7 $9.96M Mike Hampton 8-year/$121M 10.7 $11.31M This list Continue reading Best and worst current 100M+ deals
Prospects have become the baseball equivalent of backup quarterbacks. By and large we all have a fairly outsized view of their talents, and tend to forget the inherent limitations that come with their very billing. Just like a backup quarterback is a reserve because no one wants to give them a starting job, prospects are young unproven tickets who are anything but guaranteed to have solid big league careers, let alone be an All-Star or Hall of Fame caliber player. And yet, just as fans of struggling football teams will always tend to see the warts in their starting quarterback while focusing on the positive qualities of the backups (or just plain overestimate the backup’s talents), baseball fans seem to increasingly view their team’s top prospects through the prism of that player’s ceiling, while failing to realize how unlikely it is that those prospects will ever live up to their billing.
Consider Phil Hughes. Once upon a time a 21 year old Hughes was rated as the fourth best prospect in all of baseball by Baseball America, and with good reason. The previous year a 20 year old Hughes had struck out 10.7 batters per nine innings with a 4.31 strikeout to walk ratio in 116 Double-A innings. Those are tremendous numbers for any prospect, let alone someone so young for the level of competition. Add into the mix that Hughes was seen as having very good secondary pitches for someone his age, and he downright screamed “future ace.”
(click “view full post” to continue reading) Continue reading How prospect crazy have we become?
(The following is being syndicated from The Captain’s Blog). Two of the most influential members of the Yankees’ front office took to the airwaves this morning to promote the upcoming Pinstripe Bowl, and not surprisingly, each interview touched on the team’s offseason plans. President Randy Levine, who was a guest on FOX 5’s Good Day New York, and COO Lonn Trost, who appeared on WFAN’s Boomer and Carton morning radio show (hosted by Kim Jones and Chris Carlin), each fielded several questions about what the Yankees are doing, or not doing, and their responses suggested the organization has a coherent party line. Responding Continue reading Trost and Levine Take to the Air, Toe the Party Line